IL-4 receptor levels are constitutively high in CLL cells (191), which stimulates the JAK/STAT pathway that protects CLL cells from chemotherapy-induced apoptosis (192). The gene discussed is SOAT1; the disease is B-cell chronic lymphocytic leukemia.